TY - JOUR
T1 - Practical aspects of the oral new anticoagulants
AU - Deloughery, Thomas G.
PY - 2011/7
Y1 - 2011/7
N2 - After years of only oral vitamin K antagonists, there are new many new antithrombotic agents in development and on entering the marketplace. This review will analyze clinical trial results for these new agents-especially dibigatran, rivaroxaban, and apixiban. Also to be discussed are practical aspects of use of these new agents such monitoring, reversal, and use before procedures.
AB - After years of only oral vitamin K antagonists, there are new many new antithrombotic agents in development and on entering the marketplace. This review will analyze clinical trial results for these new agents-especially dibigatran, rivaroxaban, and apixiban. Also to be discussed are practical aspects of use of these new agents such monitoring, reversal, and use before procedures.
UR - http://www.scopus.com/inward/record.url?scp=79959328410&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959328410&partnerID=8YFLogxK
U2 - 10.1002/ajh.22021
DO - 10.1002/ajh.22021
M3 - Review article
C2 - 21674571
AN - SCOPUS:79959328410
SN - 0361-8609
VL - 86
SP - 586
EP - 590
JO - American Journal of Hematology
JF - American Journal of Hematology
IS - 7
ER -